Osimertinib for compound EGFR exon 19 deletion/T790M mutated lung squamous cell carcinoma.

Peng, MuYun; Wen, QiuYuan; Wu, Xia; Yu, FengLei; Liu, WenLiang

Peng, MuYun; Wen, QiuYuan; Wu, Xia; Yu, FengLei; Liu, WenLiang.

Affiliation

Peng M; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
Wen Q; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, China.
Wu X; Early-Stage Lung Cancer Center, The Second Xiangya Hospital of Central South University, Changsha, China.
Yu F; Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, China.
Liu W; Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, China.

Thorac Cancer ; 11(9): 2704-2708, 2020 09.

Article in En | MEDLINE | ID: mdl-32667739

Subject(s)

Acrylamides/therapeutic use; Aniline Compounds/therapeutic use; Antineoplastic Agents/therapeutic use; Carcinoma, Squamous Cell/drug therapy; Exons/genetics; Lung Neoplasms/drug therapy; Acrylamides/pharmacology; Aniline Compounds/pharmacology; Antineoplastic Agents/pharmacology; Carcinoma, Squamous Cell/pathology; ErbB Receptors/metabolism; Humans; Lung Neoplasms/pathology; Male; Middle Aged

Key words

Epidermal growth factor receptor; lung squamous cell carcinoma; osimertinib; tyrosine kinase inhibitor

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acrylamides / Carcinoma, Squamous Cell / Exons / Aniline Compounds / Lung Neoplasms / Antineoplastic Agents Limits: Humans / Male / Middle aged Language: En Journal: Thorac Cancer Year: 2020 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google